Osteoarthritis
Conditions
Brief summary
Comparison of the clinical effectiveness and cost-effectiveness of the MIS anterolateral approach (MIS Watson Jones, G3) versus anterolateral mini or posterolateral mini approaches in primary total hip arthroplasty
Interventions
Comparison of the clinical effectiveness and cost-effectiveness of the MIS anterolateral approach (MIS Watson Jones, G3) versus anterolateral mini or posterolateral mini approaches in primary total hip arthroplasty
Sponsors
Study design
Eligibility
Inclusion criteria
No contralateral hip symptoms, no major comorbidity
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 3-months WOMAC score | 3 months |
Secondary
| Measure | Time frame |
|---|---|
| Cost-effectiveness at 2-years | Two years |
Countries
Canada